Literature DB >> 22572745

Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.

Kai-Chen Wang1, Lin-Chung Woung, Ming-Tsu Tsai, Chih-Ching Liu, Ying-Hwa Su, Chung-Yi Li.   

Abstract

BACKGROUND/AIMS: Detailed information on the age- and sex-specific relationships between diabetes and Alzheimer's disease (AD) is scarce. This study aims to prospectively investigate the age- and sex-specific incidence density and relative hazards of AD in relation to diabetes.
METHODS: A total of 615,529 diabetic patients and 614,871 age- and sex-matched random controls were linked to the claim data from 2000-2008 to identify the first occurrence of a primary or secondary diagnosis of AD. Incidence density was calculated under the Poisson assumption. We also assessed the age- and sex-specific risk of AD in relation to diabetes with the Cox proportional hazards regression model.
RESULTS: Over nearly 9 years of follow-up, a total of 4,615 diabetic subjects developed AD, representing a cumulative incidence rate of 0.75% (n = 3,873; 0.63% in controls). The overall incidence densities of AD for diabetic men and women, respectively, were 0.82 and 1.15 per 1,000 person-years, which were higher than those for control men and women (0.63 and 0.89 per 1,000 person-years, respectively). Diabetic patients had a significantly higher hazard ratio (HR) of AD [1.45, 95% confidence interval (CI) 1.38-1.52]. Diabetic women ≥65 years had a higher HR (1.52, 95% CI 1.42-1.62) than diabetic women <65 years (1.34, 95% CI 1.15-1.56).
CONCLUSION: Diabetes may increase the risk of AD in both sexes and in all ages. A higher HR of AD was especially notable in older diabetic women.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22572745     DOI: 10.1159/000337428

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  47 in total

Review 1.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

Review 2.  New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.

Authors:  Kai Long Zhong; Fang Chen; Hao Hong; Xuan Ke; Yang Ge Lv; Su Su Tang; Yu Bing Zhu
Journal:  Metab Brain Dis       Date:  2018-04-06       Impact factor: 3.584

3.  Change in leisure and social activities and risk of dementia in elderly cohort.

Authors:  A Foubert-Samier; M Le Goff; C Helmer; K Pérès; J-M Orgogozo; P Barberger-Gateau; H Amieva; J-F Dartigues
Journal:  J Nutr Health Aging       Date:  2014-12       Impact factor: 4.075

Review 4.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans.

Authors:  Brian Downer; Mukaila A Raji; Kyriakos S Markides
Journal:  Int J Geriatr Psychiatry       Date:  2015-05-29       Impact factor: 3.485

6.  Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Authors:  E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

7.  Leptin regulates amyloid β production via the γ-secretase complex.

Authors:  Dana M Niedowicz; Christa M Studzinski; Adam M Weidner; Thomas L Platt; Kristen N Kingry; Tina L Beckett; Annadora J Bruce-Keller; Jeffrey N Keller; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2012-12-26

8.  Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study.

Authors:  Chieh-Hsiang Lu; Chen-Yi Yang; Chung-Yi Li; Cheng-Yang Hsieh; Huang-Tz Ou
Journal:  Diabetologia       Date:  2017-11-14       Impact factor: 10.122

Review 9.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Authors:  Subbiah Pugazhenthi; Limei Qin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-05-06       Impact factor: 5.187

10.  Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.

Authors:  Jui-Ming Chen; Cheng-Wei Chang; Tzu-Hao Chang; Chi-Chang Hsu; Jorng-Tzong Horng; Wayne H-H Sheu
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.